Sign inJoin waitlistJoin the waitlist

ED

Emanuel Denoia

Specialist / Research Study

Credentials: ·

Research

Lack of a clinically meaningful pharmacokinetic effect of rifabutin on raltegravir: in vitro/in vivo correlation
The Journal of Clinical Pharmacology · 2011 · 27 citations
Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose Selection
Clinical and Translational Science · 2017 · 13 citations
Intraosseous vascular access using the EZ-IO can be safely maintained in the adult proximal humerus and proximal tibia for up to 48 h: Report of a clinical study
The Journal of Vascular Access · 2022 · 5 citations

MI
Marian Iwamoto
2 papers
AB
Alina Beaton
1 paper
BM
Bradley Musser
1 paper
CK
Cassandra Key
1 paper
CD
Chris Davlantes
1 paper
DS
Daneshvari Solanki
1 paper
DK
David Krefetz
1 paper
DB
Diana Brainard
1 paper
DD
Dominick D'Aunno
1 paper
EK
Eunkyung Kauh
1 paper
JR
Juan Rondon
1 paper
KG
Keith Gottesdiener
1 paper